Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Lazorsharpon Dec 09, 2019 11:14am
124 Views
Post# 30435830

VFF 100% OF PSF

VFF 100% OF PSFLet's say EMH takes the 25% as per agreement @$5.00 a gram Q1 2020, PSF makes a killing, that's one quarter. Now can EMH do this for the remainder of the agreement until 2022 that's 11 more quarters. Personaly I don't see what they can't, although here is little "caveat" in the agreement with EMH they are required to pay upfront for the product, which is a big cash flow problem for EMH who has, lets face it, less than desirable financials. Q1 2020 EMH would have to pay PSF roughly around $35 million for the 25% as per agreement @$5 a gram.
<< Previous
Bullboard Posts
Next >>